We are accepting new cases

Hair Relaxer Lawsuit

People diagnosed with uterine, endometrial, or ovarian cancer after using hair relaxer products are filing lawsuits against the manufacturers of these chemical products.

Connect with an attorneyCheck Eligibility
Woman staring in mirror

Case Overview

Hair relaxer lawsuits allege companies like L’Oréal and Revlon manufactured dangerous products that led to people developing cancer. Studies have linked hair relaxer chemicals to multiple types of cancer, including uterine, endometrial and ovarian cancer. Women who developed these cancers after using hair relaxers may be able to file a hair relaxer lawsuit.

Important hair relaxer lawsuit updates

  • March 2026: There are now 11,440 lawsuits in the hair relaxer mass tort.
  • June 2025: The Philadelphia Court of Common Pleas consolidated approximately 25 hair relaxer lawsuits into a mass tort. This is in addition to the federal mass tort.
  • February 2025: The court has established a comprehensive bellwether trial plan for the hair relaxer MDL.

Learn about more hair relaxer lawsuit updates.

Key hair relaxer lawsuit takeaways

  • Hair relaxer lawsuits claim manufacturers failed to warn consumers about cancer risks associated with the endocrine-disrupting chemicals in relaxer products.
  • Scientific studies suggest a connection between chemical hair straightener products and uterine, ovarian and endometrial cancers.
  • Plaintiffs in federal and state lawsuits seek compensation for medical bills, lost wages and pain and suffering.

What do hair relaxer lawsuits claim?

Plaintiffs allege that manufacturers failed to warn about the health dangers of their products and, in some cases, misrepresented them as safe. The lawsuits generally claim:

  • Negligent design and formulation: Manufacturers used ingredients known to disrupt hormones and pose health hazards.
  • Failure to warn: Companies did not disclose the risks of cancer or reproductive harm despite scientific evidence suggesting a connection.
  • Deceptive marketing: Relaxers were advertised as safe for women and children, despite risks.
  • Targeting vulnerable consumers: Lawsuits argue manufacturers exploited cultural and social pressures, particularly within the Black community, to increase sales of products that carried hidden dangers.

Who qualifies for a hair relaxer lawsuit?

Women may qualify to file a lawsuit if at any point they:

  • Used chemical hair relaxers consistently for several years
  • Were later diagnosed with uterine cancer, ovarian cancer or endometrial cancer
  • Experienced related reproductive harm believed to be linked to relaxer use

Motley Rice attorneys are reviewing claims from women who meet these criteria.

Statute of limitations for hair relaxer lawsuits

The statute of limitations is the time individuals have to file a lawsuit for the harms they experienced. This deadline varies by state, making it important to seek legal advice as soon as possible if you believe you may have a case. If the statute of limitations has passed in your state, you may not be able to pursue legal action for the harms you experienced.

Motley Rice attorneys involved in hair relaxer mass torts

Motley Rice attorney Fidelma Fitzpatrick was appointed co-lead counsel for In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation, MDL No. 3060 in the U.S. District Court for the Northern District of Illinois. Motley Rice attorney Tope Leyimu was appointed to the Plaintiffs’ Steering Committee, while Mike Daly was appointed as one of two plaintiffs’ liaison counsels in the Philadelphia hair relaxer mass tort.

Motley Rice attorney Carmen Scott serves as co-lead of the Leadership Development Committee for the MDL.

Contact a hair relaxer lawsuit attorney

If you or a loved one was diagnosed with ovarian cancer, uterine cancer or endometrial cancer after using a chemical hair relaxer product, you may have legal options. To learn more, reach out to Motley Rice for a free consultation.

You can also reach our team by calling 1.800.768.4026.

Who can file a hair relaxer lawsuit? Individuals, or their loved ones, who suffered certain types of cancer after consistently using hair relaxer products may be eligible to file a lawsuit.

Cancers that may be grounds for a lawsuit include:

  • Endometrial
  • Ovarian
  • Uterine

Important terms

Endocrine system: The bodily system that creates and releases hormones. It regulates physical growth and development. The endocrine system also regulates other systems, including the nervous, reproductive and metabolic systems.

Endocrine disruption: Interference with the endocrine system’s natural function, including stopping or increasing hormone production and producing hormones when they’re not needed.

Endocrine-disrupting chemicals (EDCs): Chemicals and mixtures that hinder the normal activity of the endocrine system. They can block hormone signals by modifying DNA and cell structure.

Reproductive cancers: Cancers that affect the reproductive organs. For women, these cancers include cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, vulvar cancer and breast cancer. Endometrial cancer is a type of uterine cancer.

What are chemical hair relaxers?

Hair relaxers, a type of chemical hair straightener, are products designed to permanently change the natural texture of hair. By breaking down the protein bonds in curly or textured hair, these products create straight hair that lasts until new growth appears. Because results are temporary, many women use chemical relaxers repeatedly, often beginning at a young age and continuing for years.

These relaxers are available both as salon treatments and as over-the-counter kits marketed for home use. Despite being promoted as safe, lawsuits now allege that the repeated use of these products has exposed women to harmful chemicals. These relaxer products are capable of disrupting hormones and increasing the risk of cancers such as uterine, ovarian and endometrial cancer.

Chemicals found in hair relaxers

Most hair relaxer products contain a combination of strong chemical compounds. These include lye-based formulations (sodium hydroxide) and “no-lye” alternatives, such as guanidine hydroxide.

In addition, relaxers often include a range of endocrine-disrupting chemicals (EDCs). The endocrine system is a network of glands that produce and secrete hormones to regulate diverse bodily functions, including metabolism, growth and reproduction.

Common chemicals found in hair relaxers include:

  • Formaldehyde and formaldehyde-releasing agents: Colorless gases classified as carcinogens and often used as preservatives. In October 2023, the FDA proposed a ban on the use of formaldehyde in hair relaxers. The ban is not yet finalized.
  • Phthalates and parabens: Compounds and chemicals commonly added as stabilizers but associated with hormonal disruption.
  • Cyclosiloxanes (D4, D5, D6): Compounds found in many cosmetics, with evidence suggesting links to reproductive toxicity.
  • Octamethylcyclotetrasiloxane: Another siloxane compound associated with endocrine interference.
  • Di-(2-ethylhexyl) phthalate (DEHP): A plasticizer that can enter the body through scalp absorption.

When these chemicals penetrate the scalp, especially if burns or abrasions occur during treatment, they can enter the bloodstream and interfere with hormone function. Research cited in the hair relaxer lawsuits indicates this disruption may help explain higher rates of uterine cancer, ovarian cancer among frequent users.

People who developed cancer after using hair relaxers may be able to file a hair relaxer lawsuit.

Community forum discusses chemical hair relaxer impact on health

Tope Leyimu participated in a community forum discussing the possible health risks chemical hair relaxers may have on women’s health. The panel discussed recent scientific studies and the alleged link between the increased risk of developing certain cancers after using these products.

Watch more from CBS News.

Products and brands named in chemical hair relaxer lawsuits

Products and brands that may cause cancer and have been cited in hair relaxer lawsuits include:

  • Dark & Lovely (L’Oréal USA, Inc.): One of the most widely used relaxers, marketed heavily to women of color since the 1970s. Lawsuits claim the brand was central to long-term exposure.
  • Soft & Beautiful (Strength of Nature Global, LLC): Frequently sold in drugstores and beauty supply shops, often promoted as safe for home use despite chemical risks.
  • Optimum (L’Oréal USA, Inc.): Another L’Oréal brand, marketed as a “gentle” relaxer but alleged to carry similar health hazards.
  • Just For Me (Strength of Nature/previously Procter & Gamble): Marketed toward children, raising concerns about early and prolonged exposure to harmful chemicals.
  • Motions (Strength of Nature): Marketed as a salon-quality relaxer line, frequently used in professional settings.
  • Other brands named in lawsuits include: Olive Oil Girls, TCB Naturals and more.

These products were often promoted as safe, even for long-term or repeated use, while minimizing or ignoring health risks.

Predatory marketing and targeted demographics

A central allegation in hair relaxer lawsuits claims that these companies directed their marketing toward Black women and young girls. Studies show that Black women are two to three times more likely than white women to use chemical relaxers, often starting use at earlier ages. Plaintiffs argue that manufacturers exploited cultural pressures to conform to Eurocentric beauty standards, while downplaying or concealing potential health risks.

What health risks are linked to hair relaxers?

Emerging medical research has connected long-term use of chemical hair relaxers to a range of serious side effects and health issues, particularly cancers and reproductive system disorders.

Key risks include:

  • Uterine cancer: A 2022 National Institutes of Health (NIH) study found that women who regularly used hair relaxers were more than twice as likely to develop uterine cancer compared to non-users.
  • Endometrial cancer: Similar hormonal disruption may contribute to endometrial (lining of the uterus) cancers.
  • Ovarian cancer: Exposure to EDCs has been linked to higher rates of ovarian cancer in women who used chemical relaxers.
  • Hysterectomies: Some women who used hair relaxer products and developed cancer may have needed a hysterectomy procedure to properly treat their cancer.

These risks disproportionately impact Black women, who have historically been the primary demographic targeted by manufacturers of chemical relaxers.

Summary image discussing who is eligible to file a lawsuit, qualifying injuries, number of cases pending and brands involved in hair relaxer lawsuits.

Hair relaxer lawsuit update timeline

05.01.26

MDL numbers increased leading into May

As of May 1, there were 11,526 pending actions in the hair relaxer MDL.

04.01.26

April report showed MDL decrease

There were 11,371 pending actions in the hair relaxer MDL.

03.02.26

MDL cases grew leading into March

As of March 2, there were 11,440 pending actions in the hair relaxer MDL.

02.03.26

February MDL report shows cases increased

The hair relaxer MDL grew to 11,195 active claims.

01.05.26

New cases added to MDL

The hair relaxer MDL had 10,948 active claims.

12.03.25

Hair relaxer MDL grew

More than 100 plaintiffs filed lawsuits in November. There were 10,844 pending actions in the MDL.

11.03.25

Hair relaxer MDL actions increased again

After falling during the previous month, the number of hair relaxer cases in the MDL increased again. More than 170 new plaintiffs filed lawsuits to bring the total to 10,723.

09.02.25

MDL cases increased leading into September

There were 10,858 pending actions in the hair relaxer MDL.

08.01.25

August report shows continued MDL growth

August started with 10,567 active lawsuits in the hair relaxer MDL.

07.02.25

MDL numbers increased leading into July

There were 10,404 pending actions in the hair relaxer MDL.

06.25.25

Judge Rowland scheduled Science Day

Judge Rowland scheduled a science day for January 8, 2026. A science day is a proceeding that focuses on informing the court rather than arguing. Both sides explain the complex scientific and medical issues at the heart of the litigation.

06.17.25

Motley Rice attorney appointed as liaison counsel in Philadelphia hair relaxer mass tort

Motley Rice attorney Mike Daly was appointed one of two plaintiffs’ liaison counsels in a Philadelphia hair relaxer mass tort. In that role, he will be a point of contact between the court and other lawyers representing both plaintiffs and clients.

06.03.25

June report showed MDL growth

The hair relaxer MDL increased to 10,317 pending actions as of June 2.

05.02.25

MDL numbers increased leading into May

The hair relaxer MDL increased to 10,168 pending actions.

04.30.25

Philadelphia court established hair relaxer mass tort

The Philadelphia Court of Common Pleas established a mass tort consolidating hair relaxer lawsuits. As of late May, approximately 25 plaintiffs were in the mass tort.

04.22.25

Motley Rice attorneys appointed to MDL roles

Motley Rice attorney Fidelma Fitzpatrick was re-appointed to co-lead for the Hair Relaxer MDL, and Tope Leyimu was appointed to the Plaintiffs’ Steering Committee (PSC). Carmen Scott continues to serve as co-lead of the Leadership Development Committee.

04.02.25

April report showed MDL growth

There were 9,936 pending actions in the hair relaxer MDL.

03.03.25

March MDL numbers dipped

The hair relaxer MDL had 9,788 pending actions.

02.19.25

Judge denied motions to dismiss lawsuits

MDL Judge Mary M. Rowland of the U.S. District Court for the Northern District of Illinois denied motions to dismiss charges against several defendants. John Paul Mitchell Systems, Wella Operations US LLC and Advanced Beauty, Inc. had attempted to exit the hair relaxer cancer litigation. This ruling meant these lawsuits would stay in the hair relaxer MDL.

02.04.25

February report showed MDL growth

9,863 actions were filed and pending in the hair relaxer MDL as of February 2025.

01.31.25

Hearing held to discuss bellwether selection

A court hearing took place to discuss bellwether selection and procedure for the hair relaxer MDL. This included bellwether trial eligibility, the scope of injuries included and important upcoming deadlines. The parties must identify and exchange their initial bellwether discovery cases by April 30, 2025.

01.03.25

MDL actions grew leading into January

The hair relaxer MDL grew to 9,819 actions pending as of January 2, 2025.

12.01.24

December report revealed increase in MDL actions

The hair relaxer MDL continued to grow as more people filed new lawsuits. The total number of active cases was 9,649.

11.01.24

MDL numbers jumped entering November

Plaintiffs continued to file hair relaxer product lawsuits, bringing the total number of cases in the docket to 9,488 at the start of November.

10.01.24

October report reflected MDL growth

In October, the hair relaxer MDL contained 8,393 cases. Individuals and their families who developed a qualifying condition as a result of using hair relaxer products may still be able to join the MDL.

09.01.24

MDL actions increased going into September

The September hair relaxer MDL had north of 8,000 actions pending, marking an increase of over 500 cases from August.

08.01.24

August report indicated a decrease in MDL actions

The hair relaxer MDL shrank to 7,946 actions. Despite this decrease, new claims could still be filed in the Northern District of Illinois.

07.01.24

MDL numbers ticked up leading into July

The hair relaxer MDL grew to 8,192 actions pending as of July 1, 2024. This meant 22 more actions were filed in the previous month, alleging that hair relaxers have caused cancer in women.

06.01.24

MDL cases decreased going into June

Over 8,000 actions were pending in the hair relaxer MDL as of June 3, 2024. The year started with 8,026 actions pending. Pending actions refer to the number of individual lawsuits filed within the MDL.

05.01.24

Special Master appointment made for MDL

Discussions about appointing a Special Master to the lawsuit continued. A Special Master is a neutral person appointed by the court to help manage the complex proceedings. Professor Maura Grossman was appointed Special Master on Electronically Stored Information (ESI) discovery disputes for MDL No. 3060.

10.01.23

FDA proposed formaldehyde ban

The FDA proposed a new ban on the use of formaldehyde and formaldehyde-releasing chemicals in hair relaxers. The proposed ban acknowledged the link between formaldehyde and serious illnesses, including cancer. The proposal targeted April 2024 for the ban.

03.01.23

Motley Rice attorney appointed to MDL leadership

Motley Rice attorney Fidelma Fitzpatrick was appointed co-lead counsel for the hair relaxer MDL. A Plaintiff’s Steering Committee (PSC) was nominated. This was because the MDL had several law firms representing the various plaintiffs. The PSC would communicate with the court on behalf of all the plaintiffs. Fitzpatrick and their co-leads would preside over the actions of the PSC.

01.01.23

Hearing held on hair relaxer lawsuit consolidation

The Judicial Panel on Multidistrict Litigation (JPML) held a hearing to determine if the lawsuits would be consolidated. The defendants opposed the consolidation. But plaintiffs were optimistic the hearing would have a favorable outcome. The Panel made no formal decision.

12.01.22

Defendants argued against hair relaxer lawsuit consolidation

The defendants, including L’Oréal, argued against the consolidated MDL. The opposition to the MDL would be reviewed by the Judicial Panel on Multidistrict Litigation.

10.17.22

NIH study linked hair relaxers and uterine cancer

The National Institutes of Health studied data from the Sister Study. They concluded that women who use hair-straightening products have a higher risk of developing uterine cancer than women who don’t. Using the products more than four times a year doubled their risk of developing uterine cancer.

This study added compelling evidence linking the increase in hormone-related cancers to toxic hair relaxers. This study was released days after the original lawsuits for hair relaxers were filed in Illinois.

View Full Timeline

Frequently asked questions about hair relaxer cancer lawsuits

What brands are named in hair relaxer lawsuits?

Major brands like L’Oréal and Revlon have been named in hair relaxer cancer lawsuits. Other brand names mentioned in claims include Strength of Nature, TCB Naturals and others.

What is the average hair relaxer lawsuit settlement amount and payout?

No official payout framework exists yet. If hair relaxer settlements or verdicts are reached, compensation could include medical bills, lost wages, pain and suffering, and wrongful death damages. Early trial outcomes will help shape possible settlement amounts.

When will the hair relaxer lawsuit be settled?

Hair relaxer lawsuits are still in early stages, so there are no settlements yet. The timeline depends on scientific evidence, bellwether trials and whether defendants negotiate or fight claims. It may take years before the first payouts occur.

How do I qualify for a hair relaxer lawsuit?

Individuals may qualify to file a hair relaxer lawsuit if they used chemical hair relaxers consistently for several years, were later diagnosed with uterine cancer, ovarian cancer or endometrial cancer and experienced related reproductive harm believed to be linked to relaxer use.

A hair relaxer lawyer at Motley Rice can review specific case details and determine eligibility based on medical records and product history.

Is there a hair relaxer class action lawsuit?

Hair relaxer cancer lawsuits are not a single class action. Instead, they are consolidated in multidistrict litigation (MDL No. 3060) in the Northern District of Illinois. This allows federal courts to manage thousands of similar cases more efficiently. In 2025, the Philadelphia Court of Common Pleas also consolidated hair relaxer lawsuits into a state-level mass tort.

Our women’s health litigation experience

If you or a loved one was diagnosed with uterine, endometrial or ovarian cancer after using chemical hair relaxers, contact us today. Motley Rice is committed to helping those who have suffered life-altering health problems after using dangerous products.

Our attorneys have led toxic exposure litigation brought by thousands harmed by defective products. This includes people who developed ovarian cancer after using talc-based baby powder, those who suffered breast implant-associated anaplastic large cell lymphoma caused by Allergan implants and more.

Read more on our women's health litigation experience.

Key takeaways

What do hair relaxer lawsuits claim?

Who qualifies for a hair relaxer lawsuit?

Motley Rice attorneys involved in hair relaxer mass torts

What are chemical hair relaxers?

Products and brands named in chemical hair relaxer lawsuits

What health risks are linked to hair relaxers?

Hair relaxer lawsuit update timeline

Frequently asked questions about hair relaxer cancer lawsuits

Our women’s health litigation experience

About the Authors

Sources
  1. American Cancer Society. Formaldehyde and Cancer Risk.
  2. Bloomberg Law. John Paul Mitchell, Wella Can’t Exit Relaxer Cancer Litigation.
  3. Chang CJ, O’Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, et al. Use of straighteners and other hair products and incident uterine cancer. JNCI: Journal of the National Cancer Institute. 2022 Dec 8;114(12):1636–45.
  4. Cleveland Clinic. Uterine Cancer (Endometrial Cancer).
  5. Court Listener. In RE: Hair Relaxer Marketing, Sales Practices, And Products Liability Litigation.
  6. Court Listener. In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation, MDL No. 3060, Joint States Report for the August 29, 2024 Status Conference.
  7. Journal of the National Cancer Institute: “Endocrine-disrupting chemicals in hair relaxers and reproductive cancer risks 2024.” DOI: 10.1093/jnci/djaa123.
  8. Justia. In Re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation.
  9. Justia. In Re: Hair Relaxer Marketing, Sales, Practices, And Products Liability Litigation No. 1:2023cv00818 - Document 291 (N.D. Ill. 2023).
  10. Justia. Mitchell v. L’Oreal USA, Inc et al.
  11. La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 2020 Jan;16(1):45–57.
  12. Master Complaint. In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation, MDL No. 3060 (N.D. Ill.).
  13. Mayo Clinic. Endometrial cancer.
  14. Mayo Clinic. Ovarian cancer.
  15. Mordor Intelligence. Hair Relaxer Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030).
  16. National Cancer Institute. Prospective study of hair relaxers and fibroids in African American women.
  17. National Cancer Institute. Use of hair products in relation to ovarian cancer risk.
  18. National Cancer Institute. Use of Straighteners and Other Hair Products and Incident Uterine Cancer.
  19. National Institutes of Health. Hair straightening chemicals associated with higher uterine cancer risk.
  20. NPR. FDA move to ban formaldehyde in hair straighteners called too little, too late.
  21. NPR. The FDA is proposing a ban on hair relaxers with formaldehyde due to cancer concerns.
  22. Reuters. Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US.
  23. Slone Epidemiology Center. Hair product use and breast cancer incidence in the Black Women's Health Study.
  24. Stanford Law. Familiar Players Tapped to Lead Philadelphia’s Hair Relaxer Mass Tort.
  25. United States Judicial Panel on Multidistrict Litigation. About the Panel.
  26. United States Judicial Panel on Multidistrict Litigation. Pending MDLs.
  27. White AJ, Sandler DP, Gaston SA, Jackson CL, O’Brien KM. Use of hair products in relation to ovarian cancer risk. Carcinogenesis. 2021 Oct 5;42(9):1189–95.
  28. WTHR. Indianapolis woman who believes her hair relaxer led to her cancer diagnosis can continue lawsuit, thanks to new opinion from Georgia Supreme Court.
Your Legal Options

Start Your Motley Rice Consultation in Simple Steps

Connect with an Attorney1.800.768.4026

1

Submit Information

Call us or fill out our online form with the details of your potential case.

2

Case Review

Our team reviews your information to assess your potential case.

3

Case Consultation

Talk with us about next steps.